The risk of relapsing into depression after stopping antidepressants is high, but no established predictors exist. Resting-state functional magnetic resonance imaging (rsfMRI) measures may help predict relapse and identify the mechanisms by which relapses occur.
Introduction
A subset of those suffering from Major Depressive Disorder (MDD) achieve remission with antidepressant medication (ADM) (1) . However, this does not imply that the illness is cured as one in three of those achieving remission experience a relapse within six months after ADM discontinuation (2) . Indeed, the burden of depressive illnesses is in no small part due to their chronic nature with frequent relapses over the lifetime (3; 4) . Hence, the management of relapses is of paramount importance. In this situation, predictors of relapse risk are urgently needed to guide decision-making at key decision points such as the discontinuation of ADM after remission has been achieved.
Unfortunately, standard demographic and clinical variables appear to have very limited predictive power (5) , requiring attention to be turned to more complex measurements. Here, we examined resting-state functional connectivity -a complex yet clinically feasible neuroimaging procedure (6) .
Indeed, a growing body of research has examined resting-state functional connectivity (RSFC) in the context of depression, treatment response and relapse. The subgenual anterior cingulate cortex (sgACC) appears to have a particularly central role in the illness and treatment of depression (7; 8) : neuroimaging measures of metabolic activity within this region have been shown to have predictive power for response to antidepressant and other treatments(9; 10) and RSFC of this region is predictive of relapse independent of ADM discontinuation (11; 12) . Furthermore, abnormalities in RSFC in both the depressed (e.g. (13) ) and remitted state (e.g. (14) ) have been documented in this brain region.
The sgACC appears to exert its influence in part through connectivity to voxels in the so-called "default mode network" (DMN), the central executive network (CEN), the salience network (SN), the amygdala and the hippocampus. In MDD, the connectivity within the anterior and posterior DMN is increased and connectivity between the anterior DMN and the affective and salience network and the sgACC is also altered (15; 16) . In contrast, connectivity within the CEN and SN and connectivity to the posterior DMN are reduced (15; 16) . Connectivity changes in these regions have also been observed in remitted patients off medication and in populations with correlates of depression such as trauma, childhood maltreatment, subclinical depression and familial risk in children. These include increased connectivity between the sgACC and both the medial prefrontal cortex (mPFC) and the posterior cingulate cortex (PCC), as well as bidirectional changes in connectivity between the sgACC and the dorsolateral PFC (dlPFC), the amygdala and the hippocampus ((17; 18; 19; 20; 21; 22; 23; 24; 25; 14) ; though see also (26) ). Of note, decreased interhemispheric sgACC connectivity from the left to the right has been suggested as a marker of resilience to relapse in patients off medication (12) , while increased connectivity between the sgACC and regions in the CEN differentiates patients who will experience a relapse and those who will not (11) . A reduction in connectivity within the DMN has also been reported amongst medicated patients and those with recurrent illness (27) .
The results of studies examining the impact of ADM initiation on connectivity are heterogeneous (28; 29; 30; 31; 32; 33; 34; 35; 36; 37; 38; 39) . One of the more replicated findings is a decrease in connectivity between PCC and various brain regions (including amygdala (31) , right inferior temporal gyrus (36) , right inferior frontal gyrus (33) ), suggesting a normalisation of increased PCC connectivity with these regions in comparison to the prior, medication-free, state. Increases between the PCC and the ACC and mPFC have been reported in patients who receive treatment, but do not remit (32) .
Outstanding gaps in this literature are 1) whether RSFC connectivity differences seen in the remitted unmedicated state are also present in the remitted medicated state; 2) whether pre-discontinuation RSFC differs between patients who relapse after discontinuation and those who remain well; 3) the effects of discontinuation on RSFC; and 4) to what extent changes in RSFC due to discontinuation are related to future relapses. We here examine this in the context of the AIDA study -a two-centre observational randomized study that followed patients as they discontinued their ADM for six months. Based on the reviewed literature, we focused on the sgACC as seed region to address questions 1 and 2 and on the PCC for questions 3 and 4. : Study Design: Remitted patients on antidepressant medication (ADM) and matched healthy controls (HC) were included in the study and assessed during main assessment 1 (MA1). Patients were randomised to arms 1W2 or 12W. In arm 12W, they started discontinuation only after MA2. In arm 1W2, they discontinued their medication prior to the second main assessment MA2. After discontinuation, all patients were followed up for six months to ascertain relapses. Comparison of patient and control groups at MA1 was used to examine the remitted medicated state cross-sectionally; comparison at MA1 of patients who did and did not relapse to examine potential predictors of relapse; the interaction between MA1/2 and groups 1W2/12W to examine the impact of discontinuation; and the interaction between MA1/2 and patients who went on to relapse and those who remained well in group 1W2 to examine changes due to discontinuation that led to relapse or resilience.
Methods and Materials

Study Design
The AIDA study design is depicted in Figure 1 . Briefly, we focused on remitted patients on ADM who wanted to discontinue their medication. Participants were randomised to one of the two study arms. In arm 1W2, participants underwent the first main assessment (MA1), then gradually discontinued their medication over up to 18 weeks, and then underwent a second main assessment (MA2). In arm 12W, participants underwent two main assessments before discontinuation.
After discontinuation, all patients were contacted by telephone at weeks 1, 2, 4, 6, 8, 12, 16 and 21 to assess relapse status. Structured clinical interviews were performed if a relapse was suspected (SCID-I(40)). If these criteria were fulfilled, they underwent an in-person final assessment (FA), otherwise the final assessment took place in week 26. Healthy controls (HC) matched for age, sex and education were only assessed once (MA1).
All patients underwent a resting-state functional magnetic resonance imaging (rsfMRI), self-and observer-rated reports during each main assessment (MA1 and MA2) and HC once at MA1. See supplementary section S1.2 for observer-rated and self-report measures. Participants were recruited between July 2015 and January 2018.
Participants
The AIDA study recruited participants who had experienced one severe (41) or multiple depressive episodes; had initiated antidepressant treatment during the last depressive episode and now achieved stable remission; and had reached the decision to discontinue their medication independent from and prior to study participation. Detailed inclusion and exclusion criteria are listed in the supplementary section S1.1. All participants gave informed written consent and received monetary compensation for the time of participation. Ethical approval for the study was obtained from the cantonal ethics commission Zurich (BASEC: PB_2016-0.01032; KEK-ZH: 2014-0355) and the ethics commission at the Campus Charité-Mitte (EA 1/142/14). Amygdala seeds were extracted from the Harvard-Oxford Subcortical Probability Atlas by including all voxels with at least 80% probability of being in the amygdala. For each analysis, one seed was designated a priori as the main seed of interest and the other six as exploratory seeds.
Seed Region Selection
Resting-state fMRI analysis 2.4.1 Image acquisition and preprocessing
The sequences used for image acquisition are described in the supplementary section S1.4. Imaging data was preprocessed with a FSL (FMRIB Software Library v5.0) pipeline detailed in supplementary section S1.5.
Connectivity estimation
First level analyses were conducted with the CONN toolbox (44) . We included motion regressors (see section motion correction for details), 10 regressors computed using aCompCor in the CONN toolbox (5 principal components of white matter and cerebrospinal fluid signals each), and bandpass filtered the data to retain frequencies between 0.01 and 0.1 Hz. All covariates were also regressed out of the seed regions. Then, the average signal of all voxels within subject-specific grey matter masks of each seed was computed and correlated with all voxels in the brain. Resulting correlation coefficients were z-transformed for second-level analyses.
Motion and study site effects
Analyses to control for effects of motion and study site are described in detail in supplementary section S1.6 and S1.7. Subjects with a framewise displacement (FD) of 1mm from one volume to the next and with a mean SNR smaller than 30 were excluded from further analyses.
Second-level analyses
Second-level analyses were conducted with SPM12 (version: v7219). For all analyses with our chosen main seed, we report peak-level results family-wise error (FWE) corrected at the voxel level at 0.05 and depict the respective clusters in figures. Altered RSFC of the selected seeds in acute and remitted depression has mainly been reported for voxels which are part of the DMN, the CEN, the SN, the amygdala and the hippocampus (16; 15; 17; 19; 21; 22; 23; 14) . As FWE-corrected results depend on the search volume of the analysis, we constructed an "affective mask" containing all voxels within the DMN, the CEN and the SN, as well as voxels within anatomical masks of the bilateral amygdalae and the hippocampi ( Figure 2B ) as these areas show abnormal RSFC in affective disorders.
Exploratory analyses were considered significant after Bonferroni correction for all six seeds at p=0.0083.
Our first analyses focused on the first assessment MA1. To identify abnormalities persisting into the remitted medicated state we compared RSFC between the left sgACC and the affective mask between patients and HC using an independent-sample t-test. To identify markers of prospective relapse, we repeated this analysis comparing patients who did and did not go on to relapse. Exploratory analyses examined the RSFC between the affective mask and the right sgACC, the left PCC, right and left amygdala and right and left dlPFC seed regions.
Next, we examined the impact of discontinuation. To test the hypothesis that RSFC between the PCC and the affective mask would increase due to discontinuation, we applied a mixed-design analysis of variance (ANOVA) with group (1W2 and 12W) as between-subject factor and time point as within-subject factor (MA1 and MA2).
Where significant interaction effects were found, we conducted the following post-hoc tests: paired sample t-test in group 1W2 to identify changes related to discontinuation; paired sample t-test in group 12W to investigate testretest reliability and an independent sample t-test between group 1W2 and 12W at MA1 to verify that no random allocation differences occurred prior to discontinuation. We repeated this analyses using the right and left sgACC, right and left amygdala and right and left dlPFC as seeds for exploratory analyses.
Finally, we attempted to gain insight into how the effects of discontinuation might relate to relapse. For this, the above analyses were repeated within group 1W2 only using relapse as between-subjects factor. Post-hoc paired sample t-tests were performed within the relapse group to identify changes related to relapse and paired t-tests in the no-relapse group to identify changes related to resilience.
Additional sanity checks and exploratory analyses are described in supplementary section S1.8.
Covariates
RSFC that were found to differ significantly between or within groups were correlated with several covariates including age, gender and site as covariates of no interest and rumination score, residual depression score, medication load and disease severity. Computation of medication load and severity factor is outlined in supplementary section S1.3. (+ X) indicates the number of participants who either relapsed or did not relapse but did not have useable data at MA2.
The consort diagram (Figure 3 ) shows numbers at each study stage and reasons for dropouts. Briefly, 66 healthy controls were included. Of these, 7 dropped out before MA1, 4 were considered pilot data, 4 did not have usable resting-state data, 1 was excluded from all analyses due to a lack of adherence to instructions and 6 were excluded due to motion. Demographic and clinical characteristics are displayed in Table 1 . Patients scored higher on the rumination brooding subscale. This was particularly accentuated in patients who went on to relapse. 69% of our sample took a selective serotonin reuptake inhibitor, 27% a serotonin-norepinephrine reuptake inhibtor and 4% an antidepressant from a different class. 
Motion and site effects
Comparing participants with high and low motion during MA1 yielded no significant difference between these groups for any of the seeds. Hence, we decided to only exclude participants with FD > 1 between two volumes but added no additional motion regressors and did not censor any scans with stick regressors. There was an effect of site on the temporal signal-to-noise ratio (t(126)=7.76, p<0.001, Figure S1 ). To examine if this impacted significant effects, we correlate the according RSFC with site as covariate of no interest.
Overall connectivity
Overall seed connectivity across all participants at MA1 replicated patterns established in the literature (Figure S2 ).
The remitted and medicated state
The left sgACC was designated as the main a-priori seed. RSFC with voxels in the affective mask did not differ between remitted patients on ADM and controls. No differences were found for any of the exploratory seeds.
Relapse effects
The left sgACC was designated as the main a-priori seed. RSFC with voxels in the affective mask did not differ between patients who did and did not go on to relapse. No differences were found for any of the exploratory seeds.
Discontinuation effects
The left PCC was designated as the main a-priori seed. RSFC with voxels in the affective mask did not show an interaction between time (MA1/2) and group (1W2/12W). No interaction effects were found for any of the exploratory seeds.
Relationship between discontinuation and relapse
A significant interaction between discontinuation and relapse emerged for RSFC between the right dlPFC and two peaks in the right posterior DMN, namely in the parietal cortex ( Figure 4A cortex ( Figure 4A,D) . Post-hoc tests did not reveal differences between relapsers and non-relapsers before discontinuation. The significant interaction was driven by an increase in RSFC in patients who discontinued but did not go on to relapse: RSFC between the right dlPFC and the right parietal cortex increased with discontinuation in those who remained well ( Figure 4A ,C; note the slight shift in the parietal cortex for the post-hoc test depicted in blue), while it decreased numerically without reaching statistical significance in those who went on to relapse.
None of the post-hoc tests on the connectivity between right dlPFC and PCC reached significance. These effects did not remain significant when including participants with more than 1mm FD and censuring the scans with stick regressors.
Exploratory analyses without correction for multiple comparisons
No significant effects emerged for any of the exploratory seeds in any of the analyses when we dropped the correction for multiple comparison for number of seeds and set the required significance level to 0.05 FWE-corrected.
In Table S1 , we additionally report results for RSFC for our main seeds for all analyses at an uncorrected significance level of 0.001.
Covariates
We correlated RSFC between the right dlPFC and the cluster in the parietal cortex in non-relapsers before they discontinued as well as the change accompanying the discontinuation with our pre-specified covariates, but found no significant correlations.
Discussion
We examined resting-state functional connectivity in the context of antidepressant discontinuation in stable remission from Major Depressive Disorder. There are several negative results that are in part notable because the analyses focused on the sgACC and other well-established regions as seeds, and a narrowed set of regions as targets. First, we found no difference between remitted, medicated patients and matched controls. Second, patients who went on to relapse after ADM discontinuation did not differ from those who remained well. Third, discontinuation did not result in changes in RSFC between the PCC and voxels within our affective mask, nor any of the exploratory seeds.
The only positive finding pertains to the subgroup of patients who were tested before and after discontinuation.
Only those who remained well during the follow-up period showed an increase in RSFC between the dlPFC and two areas in the posterior DMN, namely the parietal cortex and the PCC, whereas patients who went on to relapse did not show this increase and instead showed a numerical decrease that did not reach statistical significance.
Before discussing potential interpretations of the individual null findings, we highlight the difficulties inherent in interpreting the absence of an effect, and we note the problems around reliability of RSFC measures for brief scans as in our study (47) . Although these results do not provide evidence for the absence of effects, power considerations can guide the interpretation by suggesting the size of effects a study of this size should have identified. Two-tailed two-sample t-tests comparing 84 patients to 44 healthy controls and 29 relapsers to 38 nonrelapsers have a power of 0.8 to detect medium (d=0.52) and large (d=0.70) group differences, respectively, and a power of 0.95 to detect effects of d=0.67 and 0.90, respectively (using G*Power 3.1 (48) ). As such, large effects above 0.5 are unlikely, and hence we judge it unlikely that resting-state connectivity revealed with a seed-based approach based on short scans as in this study have clinical utility (49) .
The absence of significant RSFC differences between remitted MDD patients on ADM and healthy never-depressed controls contrasts with results in the literature (21; 14) . The sample size in the current study was larger than in most previous studies. We also carefully excluded possible differences in the analysis pipelines. The only major difference between previous and the present study is the medication status: all previous involving remitted patients focused on unmedicated samples (17; 19; 21; 22; 23; 14) . In contrast, our patient group had been medicated for a median duration of two years. The interpretation of an absence of previously reported effects is of course difficult. Nevertheless, the absence of findings in our sample compared with the existence of effects in unmedicated samples raises the possibility that longer-term treatment might broadly normalise abnormal RSFC of the sgACC as well as of other seeds to the DMN, the CEN and SN in patients with sustained remission in response to such treatment. The absence of increased RSFC in the DMN is particularly striking given that our patient sample in the remitted and medicated state was still characterised by slightly increased rumination as assessed through self-report (50) . However, our study design does not allow us to disentangle a potential normalisation from the effects antidepressants have on the BOLD signal(51; 52).
The absence of differences in RSFC between patients who went on to relapse and patients who remained well after ADM discontinuation is similarly surprising, given that relapse and resilience independent of discontinuation have been reported to be associated with abnormal RSFC of the sgACC (11; 12) . We again note that our sample was assessed in the medicated state before discontinuation. The absence of a difference in our study raises the possibility that previous findings relate more broadly to relapse risk, and that our lack of findings speaks only to the specific induction of relapse through discontinuation. Such a discrepancy might mirror results from clinical predictors such as number of prior episodes, which are thought to increase the risk of overall relapse (53) . Two meta-analyses examining the role of number of prior episodes in relapse after ADM discontinuation, however, came to diametrically opposing conclusions(54; 55). These results suggests that the number of prior episodes might relate to overall relapse risk, but not to relapse risk specifically after ADM discontinuation. It is interesting to consider why connectivity appears to have higher prognostic value in current MDD compared to remitted MDD (12) , and why reactivating depression-relevant cognitions also led to stronger predictive performance (56) .
One possible explanation could be provided by Teasdale's differential activation hypothesis(57; 58) according to which depressogenic thoughts and hence depression-related neural activity patterns need to be reactivated in the remitted state in order to be visible (59) .
Next, ADM discontinuation did not reveal any effects. This result, again, is unexpected given that ADM initiation has been shown to induce changes in the connectivity of the PCC(36; 31; 33). One potential explanation could be that the timing of the second measurement five half-lives after ADM discontinuation was too early to see effects.
This would in turn suggest a normalisation of RSFC lasting into the unmedicated state.
Finally, our data suggests that an increase in RSFC between the right dlPFC and the posterior DMN, in particular the parietal cortex, relates to resilience to relapse after ADM discontinuation. An effect of this kind was expected a priori as it reflects prior findings showing a decrease in PCC connectivity with ADM initiation(36; 31; 33). However, unlike previous reports of an increase in the RSFC of the CEN in those who go on to relapse(11), we here observed an increase in right dlPFC-parietal connectivity in patients who remained well. These findings hence point towards a compensatory effect in response to discontinuation that might protect patients from relapse. While the default mode has been related to rumination, the right dlPFC has been extensively related to regulation(60) and conceptual-emotional information integration (61) . It is hence tempting to speculate that the increase in connectivity might reflect emotion regulation strategies and rumination, both of which influence the course of depression(62; 63).
Limitations and Strengths
The study has both strength and limitations. Amongst its strengths is that, to our knowledge, this is the first study examining neurobiological effects in the context of ADM discontinuation and relapse thereafter. The lack of findings and replications in our study, however, might result from some of its limitations. First, the restingstate scan was only 5.5min, which is relatively short. Second, the evidence in favour of abnormal RSFC of the sgACC, on which we based our hypotheses and analyses, is admittedly heterogeneous and also does rely on partially overlapping samples (17; 21; 22; 23) . Third, the signal-to-noise ratio differed between the study sites, potentially reducing the power to find effects in the bigger sample from Zurich. Fourth, the fact that patients were on medication from several classes might have increased the heterogeneity of the medications' influence on RSFC and in that it reduced the power to identify significant effects. Fifth, no standard approach for motion correction exists. Hence, cut-off choices are arbitrary. To avoid spurious correlation due to motion(64; 65), we choose a priori a more conservative criterion by excluding all participants with more than 1mm FD. Sixth, the naturalistic design does not allow us to disentangle pharmacological effects of discontinuation from the potential psychological effect of knowing that the ADM is discontinued. Finally, these analyses followed previous studies of RSFC in depression, which primarily used a seed-based approach. More advanced analyses could yet reveal meaningful changes.
Conclusion
We found no RSFC differences between remitted, medicated patients and healthy controls, between relapsers and non-relapsers or as a consequence of discontinuation. This raises the possibility -but emphatically does not
show -that antidepressants normalise RSFC and that this normalisation persists at least for a brief period into the unmedicated state. We did, however, find tentative evidence for a potential marker of resilience to relapse after ADM discontinuation in terms of an increased connectivity between the right dlPFC and the posterior DMN.
Supplementary Material
S1 Supplementary Methods
S1.1 In-and Exclusion Criteria
In x 0.60mm, flip angle: 9 • ) were also acquired.
S1.5 Preprocessing
Functional images were realigned, slice-time corrected and smoothed with a 6mm FWHM kernel using adaptive spatial procedure (SUSAN (6)) in FSL (FMRIB Software Library v5.0). The images were then co-registered to the structural image and normalised using Advanced Normalization Tools (ANTs (7)). Finally, an independent component analysis-based artefact removal (ICA-AROMA (8)) was applied to exclude noise components relating e.g. to breathing and heart rate, using a data-driven approach and the data was subjected to a high-pass filter of 0.008Hz. Lastly, BOLD data were normalised to MNI standard space, applying the registration matrices and warp images from the two previous registration steps, and then resampled into 2 mm isotropic voxels. All imaging data were visually inspected to exclude acquisition artefacts or other data corruption.
S1.6 Motion correction
As group differences can be confounded by head motion differences(9), we excluded participants from all analyses if their frame-wise displacement (FD) from one volume to the next exceeded 1mm at any time during the scan. To test for the effects of motion, we performed a median-split based on the mean FD and compared RSFC for all seeds between all participants included at MA1. In case effects were negligible, we used 6 realignment parameters as motion regressors on the first level and no further correction to avoid over-fitting and power reduction.
In case non-negligible motion artefacts were observed, we would have additionally added the 6 derivatives of the realignment parameters and censored those scans for which FDs were bigger than 0.5. Censoring scans means to include an additional regressor for each volume at which the movement exceeds a given threshold, here 0.5
FD. This regressors contains zeros at all volumes but the volume that exceeds the threshold. At that volume, the regressor contains a one.
S1.7 Study site effects
To examine systematic differences between the two study sites, we compared the temporal signal-to-noise ratio in the grey matter for all included subjects between sites.
S1.8 Sanity checks and exploratory analyses
To specifically examine effects of time, paired t-test in patients who did not discontinue but were assessed twice (group 12W) were conducted.
To explore whether we missed strong abnormalities that were outside our restricted search volume, i.e. the affective mask, which might be of interest for future studies, we repeated all second level analyses without the affective mask in whole-brain analyses. In addition, we report results without correction for multiple comparison for number of seeds and uncorrected results at a significance level of 0.001 for all main seed analyses to allow for estimates of potential type II errors.
S2 Supplementary Results
Berlin Zurich 
S2.1 Quality checks
To ensure that functional connectivity between our chosen seeds and the anticipated networks based on the literature was evident, we visually inspected the networks connected to the seeds in all participants included for analyses at MA1. Figure S2 depicts these networks for all seeds in the left hemisphere. Network functional connectivity seems as expected.
S2.2 Effects of time
There were no significant changes in RSFC for any of the seeds in patients who were assessed twice prior to discontinuation. 
S2.3 Whole-brain exploratory analyses
Repeating all second level analyses without the affective mask led to the similar significant clusters as reported for the within mask analyses, whereas the p-values naturally differed (parietal cortex: p=0.021, PCC: p=0.004).
Of note, no additional effects emerged. Table S1 depicts results for all main seeds considered significant at 0.001 without correction. The sparsity of results at this significance level speaks against a high rate of type II error due to correction for multiple comparison, but supports the null hypotheses for many of the examined effects. 
S2.4 Uncorrected results
